"1957-02-27Z"^^ . "Nicholas B. Lydon FRS (born 27 February 1957) is a British scientist and entrepreneur. In 2009 he was awarded the Lasker Clinical Award and in 2012 the Japan Prize for the development of Gleevec, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia (CML), which converted a fatal cancer into a manageable chronic condition."@en . "Nicholas Lydon"@en . . "British biochemist" . . . "1957Z"^^ . . . . "Lydon, Nicholas"@en . . .